Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

THE TRUTH ABOUT: Zosano pharma s return on capital employed insights | History Defined

According to data from Benzinga Pro, during Q4, Zosano Pharma's (NASDAQ:ZSAN) reported sales totaled $87.00 thousand. Despite a 19.58% increase in earnings, the company posted a loss of $6.97 million. In Q3, Zosano Pharma brought in $252.00 thousand in sales but lost $8.67 million in earnings.

Why Is ROCE Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.